Table 3.
Hormone abnormality | Linac | Tomo Therapy | Gamma knife | Total (%) |
---|---|---|---|---|
GH | 4 | 1 | 0 | 5 (25) |
PRL (↓) | 1 | 0 | 0 | 1 (5) |
PRL (↑) | 2 | 1 | 1 | 4 (20) |
ACTH | 2 | 0 | 0 | 2 (10) |
TSH | 3 | 2 | 0 | 5 (25) |
LSH/FSH | 3 | 0 | 0 | 3 (15) |
Total | 15 | 4 | 1 | 20 (100) |
Hormone abnormality | Linac | Tomo Therapy | Gamma knife | Total (%) |
---|---|---|---|---|
GH | 4 | 1 | 0 | 5 (25) |
PRL (↓) | 1 | 0 | 0 | 1 (5) |
PRL (↑) | 2 | 1 | 1 | 4 (20) |
ACTH | 2 | 0 | 0 | 2 (10) |
TSH | 3 | 2 | 0 | 5 (25) |
LSH/FSH | 3 | 0 | 0 | 3 (15) |
Total | 15 | 4 | 1 | 20 (100) |